Bronchiectasis is a chronic respiratory disease. People with the condition experience difficulty in clearing mucus from their lungs, leaving them prone to infections. Oral steroids have a place in the management of acute and severe asthma. In bronchiectasis, inhaled steroids have small benefits but there is no evidence for or against the use of oral steroids for this condition.
閱讀完整摘要
Inflammation plays a significant role in the pathophysiology of bronchiectasis. Two small studies have shown small benefits from inhaled corticosteroids and oral corticosteroids may be of benefit in bronchiectasis
目的
To determine the efficacy of oral corticosteroids in acute and stable bronchiectasis
搜尋策略
The Cochrane Airways Group Specialised Register was searched and bibliographies of retrieved papers were checked. Searches are current as of May 2011.
選擇標準
Only randomised controlled trials were considered
資料收集與分析
No trials met the inclusion criteria for the review.
主要結果
No randomised controlled trials were identified
作者結論
There are no randomised trials upon which to base recommendations about the use of oral corticosteroids in acute or stable bronchiectasis.
